Biotech Acquisition Company logo
Biotech Acquisition Company BIOTU
$ 10.14 -7.65%

Quarterly report 2022-Q2
added 08-22-2022

report update icon

Biotech Acquisition Company Balance Sheet 2011-2024 | BIOTU

Annual Balance Sheet Biotech Acquisition Company

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - - - - - - - -

Long Term Debt

- - - - - - - - - - -

Long Term Debt Current

- - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - -

Total Current Liabilities

314 K 69.5 K - - - - - - - - -

Total Liabilities

27.5 M - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - -

Retained Earnings

-27.2 M - - - - - - - - - -

Total Assets

230 M - - - - - - - - - -

Cash and Cash Equivalents

91.4 K - - - - - - - - - -

Book Value

203 M - - - - - - - - - -

Total Shareholders Equity

-27.2 M 20 K - - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Biotech Acquisition Company

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - 13.5 M 22.8 M 27.5 M 20.6 M 24.1 M 19.2 M 69.5 K 69.5 K 69.5 K 69.5 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - -13.4 M -22.5 M -27.2 M -19.9 M -2.53 M 2.54 M -5 K -5 K -5 K -5 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - 230 M 230 M 230 M 231 M 231 M 232 M 89.5 K 89.5 K 89.5 K 89.5 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - 1.7 K 104 K 91.4 K 402 K 936 K 677 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - 217 M 208 M 203 M 210 M 207 M 212 M 20 K 20 K 20 K 20 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - -13.4 M -22.5 M -27.2 M -19.9 M -22.8 M -17.7 M 20 K 20 K 20 K 20 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency